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Abstract: The primary aim of this article was to improve the solubility and bioavailability of the drugs nifedipine, niclosamide, and
furosemide due to their poor solubility and dissolution rate. Therefore, these drugs require improvement in solubility and dissolution
rate in formulation development, especially in solid dosage forms such as hydrogels and capsules. Hydrogel structures were synthesized
by using a biocompatible, nontoxic, and protective pure 2-hydroxy ethyl methacrylate (HEMA) monomer. These hydrogel structures
were characterized by various techniques such as scanning electron microscopy and Fourier-transformed infrared spectroscopy. In the
next step, drug molecules were loaded in the poly (HEMA) hydrogels. Drug releases of drug-loaded hydrogel structures were measured
at certain time intervals and recorded cumulatively (%). The pH affinity, morphology, structure, drug release, swelling, and cytotoxic
effect of the resulting materials were studied in detail. In addition to investigating the biocompatibility and cytotoxicity of the poly
(HEMA) hydrogel, we evaluated an in vitro cytotoxicity assay on MCF-7and MIA PaCa-2 and HEK 293 cell lines with the hydrogel
structure and confirmed cell viability of over 85%. These results suggest that our HEMA polymeric hydrogel is a material with biological
importance and great pharmacological potential as a supporting material in the drug release of nifedipine, furosemide, niclosamide,
and similar drug molecules.
Key words: Hydrogel, drug release, cytotoxicity, furosemide, nifedipine, niclosamide

1. Introduction
Recently, different controlled drug delivery applications for the treatment of diseases have become available in modern
medical technology [1]. Choosing the appropriate route of application affects how easily a drug reaches the target area,
drug dosage, and dosage regimen [2]. It may thus be highly beneficial to monitor the release behavior of the drug delivery
platform [3]. This platform can be useful for the continuous treatment or for targeted, site-specific drug release [4].
One potential way to gain control over the release behavior is the application of a smart polymer coating [5]. The smart
polymeric coating can serve several purposes simultaneously in such systems. Polymeric encapsulation, which restricts
environmental exposure, may achieve stabilization of the solid state of a drug [6]. Besides, these coatings may be helpful
for several therapies as they make possible controlled drug release and reduce serious side effects [7]. The main functions
of drug delivery systems are based on the mechanism of safely moving the drug to various parts of the body, controlling
the amount of medication [8-9], and duration of treatment [10-11]. In drug release, most of the characteristics of a
carrier material are required, such as biocompatibility, nontoxic immunogenicity deficiency, repeatability, and continuous
activation to the target [12]. Stimulant-sensitive hydrogels that show great potential in a variety of pharmaceutical and
biomedical applications have been one of the latest advances in carrier materials science [13].
Hydrogels have various uses in biomedical applications [14]. At the same time, they are well-suited for regenerative
medicine and controlled drug delivery [15]. Hydrogels are networks of hydrophilic homopolymers or copolymers that
inflate water and these are biological fluids that are absorbed [16]. Due to these characteristic features, hydrogels offer
important opportunities for drug delivery systems [17]. In particular, hydrogel structures can cause a slow decomposition
and release of a water-insoluble drug. They can also protect the drug from stomach acid and enzyme corrosion, thus
improving the stability of the drug [18-19]. Hydrogels improve the release behavior, degradation, and stability of drugs,
such as furosemide, niclosamide, and nifedipine by maintaining drug concentration and overcoming biological barriers to
cellular uptake in a therapeutic study [19-20].
* Correspondence: baharyilmaz@kmu.edu.tr
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The drugs niclosamide, furosemide, and nifedipine are water-insoluble, antiinflammatory drugs used to relieve
cardiovascular disease or inflammation [20-21]. Nifedipine is an effective calcium channel blocker widely used in various
cardiovascular diseases for clinical management [22]. In a number of cases, furosemide is a loop diuretic that is used orally
to change the amount and/or composition of body fluids, including hypertension heart failure, renal failure, nephrotic
syndrome, and cirrhosis [22-24]. Niclosamide has been recognized as an anthelminthic drug almost since it was known.
Moreover, it is an active medication against most tapeworms [25]. Niclosamide is also used as a molluscicide for sewage
treatment in schistosomiasis prevention programs [26]. However, the emergence of the anticancer properties of niclosamide
has been in the recent past. Recently, there has been a notable increase in studies showing the anticancer effect of the drug
niclosamide against many cancer diseases, such as the ovary, prostate, colon, and breast cancer [27-28]. Recent studies
show that hydrogel structures and/or nanofiber structures increase the preservation of these drugs by forming host-guest
complexes [29-30]. At the same time, the use of hydrogels as a unifying matrix prevents the degradation of nifedipine,
niclosamide, and furosemide [28]. Therefore, the main functions of hydrogels are to prevent drug release behavior and
drug degradation in drug delivery applications.
In the field of drug delivery, there are many studies on combining polymeric structures such as hydrogels and films
[31-32]. However, there are only a limited number of studies performed on the inclusion of low-resolution active agents
such as anticancer drugs, antibacterials, essential oils, and aromas into hydrogel [33-34]. Hydrogels can exhibit the same
mechanical properties (water content, biocompatibility, transport mechanism, etc.) as soft tissues [35]. They can therefore
be used as physical models for solid tumors or integrated into drug and biomolecule release studies [36-37]. HEMA
hydrogel was used as supporting material for rapid in vitro assessment of three drug release profiles: niclosamide, nifedipine,
and furosemide [38-39]. These drug molecules are generally used to support cancer drugs. These drug molecules with
low solubility were loaded onto the HEMA hydrogel to improve bioavailability and protection [40-41]. The comparative
cytotoxic effects of these drug molecules were studied for the first time in this study. Thus, it was determined that the drug
molecules showed a more cytotoxic effect thanks to the HEMA hydrogel.
The objective of this study was to examine the release of low water solubility drug molecules from hydrogel (furosemide,
nifedipine, and niclosamide) and their effect on cancer cells. Therefore, synthetic, biodegradable, and HEMA-based hydrogels
were created. The preservation of furosemide, nifedipine, and niclosamide structures was improved by complexing with the
hydrogel structure of HEMA. Then, the release of drug molecules from the hydrogel structure was enabled. Cytotoxicity
tests of the released drug molecules against MCF-7, HEK 293, and MIA PaCa-2 cell lines were performed. The results
showed that HEMA hydrogel structure can hold great promise in promoting the preservation and release of drugs into cells.
2. Materials and methods
2.1. Materials
2-Hydroxyethyl methacrylate, ≥99%, (HEMA), MBA (N-N’ methylenebisacrylamide), APS (Ammonium persulfate),
and TEMED (N,N,N′,N′-Tetramethyl ethylenediamine), drug molecules (nifedipine, niclosamide, and furosemide) were
obtained from Sigma and Merck. The phosphate buffer solution, the HEMA hydrogel, and drug solutions were prepared in
our laboratory. Besides, breast carcinoma line MCF-7 (ATCC ® HTB-22 ™), pancreatic carcinoma line MIA PaCa-2 (ACC
733, DSMZ), and epithelial HEK-293 (ATCC ® CRL-1573 ™) lines were purchased from Sigma.
2.2. Synthesis of HEMA hydrogels
Poly (HEMA) hydrogels were synthesized by the bulk polymerization method. This method involves only the
HEMA monomer molecule, an initiator APS (Ammonium persulfate), and crosslinker agents such as MBA (N-N’
methylenebisacrylamide) and TEMED (N,N,N′,N′- Tetramethyl ethylenediamine). The monomer is taken in the liquid
state and the initiator is dissolved in the monomer [28]. In this way, the monomer mixture was prepared. HEMA (0.137
mL) and other components of APS (0.002 g), MBA (0.0077 g), and TEMED (10 µL) were dissolved/dispersed and then
they were mixed at room temperature under magnetic stirring at 400 rpm. After complete dissolution, the mixtures were
injected into molds of glass plates. The molds were transferred to an environment where polymerization was carried out at
+4 °C for 12 h and then at –20°C for 24 h [28].
2.3. Drug loading
Prepared hydrogels were weighed and immersed in PBS solution (4 mL, 0.01 M, pH 7.0) containing 0.2 mg/mL drug. The
hydrogels were incubated at room temperature without shaking and samples (100 µL) of the drug loading solution were
collected at predetermined time points for up to 24 h. The amount of loading furosemide, nifedipine, and niclosamide drugs
in hydrogel samples was determined using an UV–Vis spectrophotometer at 513, 440, and 340 nm, respectively. The drug
concentration was determined by spectrophotometric measurements, and the amount of drug loaded on the hydrogels
was calculated from the difference between the initial and final drug amount in the loading solution [15] (Schema).
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2.4. FT-IR analysis
The structure of 2-Hydroxyethyl methacrylate (HEMA) hydrogels and drug-loaded HEMA hydrogels were characterized
by performing FT-IR spectroscopy. Fourier transform infrared attenuated total reflectance spectra were recorded using
FT-IR spectrophotometer (Bruker Vertex 70 ATR-FTIR) over the range 4000–400 cm−1.
2.5. Morphology
The morphology and structure of the HEMA hydrogels were examined by scanning electron microscopy (SEM). Hydrogel
samples were coated with 5 nm Au prior to SEM imaging. The SEM images of hydrogels were obtained at a distance of
approximately 1 µm.
2.6. Swelling measurement
Equilibrium swelling (ES) of free hydrogels was determined in distilled water and different buffer solutions. HEMA
hydrogels have been immersed into 50 mL of prepared solution at 25 °C for 18h to reach maximum swelling capacity.
Equilibrium swelling % (ES) = (W2 − W1)/W1× 100
where W1 is the initial dried sample weight, and W2 is the sample weight after 18 h swelling [16]. The swelling ability of
the hydrogels was also determined in different buffers (pH 2, pH 4, pH 7, and pH 9). All these experiments were repeated
three and/or four times.
2.7. In vitro drug release of HEMA
The drug release amount of drug-loaded HEMAs was determined hourly by the UV spectrophotometer in a predetermined
buffer solution (Shimadzu UV 1800). All the measurements were completed in 96 h. All results were performed in triples
and presented in the unit of cumulative release as seen in the following equation [23].
Cumulative release = Mt/M0 × 100
where M0 is the amount of drug preloaded into the hydrogel and Mt is the amount of drug released.
2.8. Cell culture and viability assay
Cell viability assessment was performed on MCF-7 (human breast adenocarcinoma), MIA PaCa-2 (human pancreatic
carcinoma), and HEK 293 (human embryonic kidney 293) cell lines by using Alamar blue method. This method is based
on color changes during the reduction of Alamar blue. It is also a common method used to test cell proliferation, viability,
and/or cytotoxicity. Ninety-six-well plates containing pure HEMA and drug-loaded HEMA were prepared. The cells were
seeded into these 96-well plates at a density of 10,000 cells/well. Each cell of the well containing 100 µL DMEM medium
was incubated at 37 °C with 5% CO2 for 72 h. Next, 10 µL of Alamar reagent (per well) was added to each well and
incubated at 37 °C, 5% CO2 for 4 h. After incubation, the absorbance of each well was measured at 560–600 nm. Following
the incubation, the absorbance of each well was measured at 560–600 nm by using an iMark Microplate Reader (Bio-Rad)
[30].
2.9. Detection of cytotoxicity in artificial blood samples
Cancer cells containing artificial blood (RBCs of expired human blood schema) were used for cytotoxicity studies. Once
cancer cells with artificial blood were cultured at 80 µg/mL in these 96-well plates, drug molecules were added. Cell
survival was observed by using the standard Alamar blue assay. Following 24-h incubation, the cultured medium was
removed and replaced. Alamar blue in PBS was added and incubated at 37 °C for 4h. After incubation, the absorbance of
each well was measured at 560–600 nm by using an iMark Microplate Reader (Bio-Rad) [42-43].
3. Results
The production of hydrogel delivery systems should preserve the bioactivity of the drug. Both the HEMA hydrogel and the
drug (nifedipine, niclosamide, and furosemide) must be chemically and physically stable during packaging, transportation,
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and storage processes. HEMA-based hydrogels are structures that usually belong to the group of swelling, drug release,
and controlled drug delivery systems. The preparation process of HEMA-based hydrogels is presented in Figure 1. In
this work, bulk polymerization was used. The reaction between APS and TEMED was the first step of polymerization:
Homolytic cleavage of APS fragments accelerated by TEMED created free radicals. We successfully synthesized HEMAbased hydrogel. The prepared HEMA hydrogel formed a complex with drug molecules that have low water solubility
(Figure 1). The binding between the drug and HEMA was provided by noncovalent interactions, such as π-π, CH-π,
electrostatic interaction, H-binding, and hydrophobic interaction [34-35]. When the drug is released, the hydrogel should
be planned and designed either to degrade to avoid surgical removal or to be reused by drug refilling. These opportunities
provided by HEMA are most likely due to the inclusion of the nonpolar parts of these molecules in the nonpolar spaces of
HEMA [36]. The interaction between hydrogel and drug molecules decays in the presence of suitable environments. This
is because our hydrogel structures swell only in the presence of suitable environments. The bulging hydrogel structures
realize the release of drug molecules.
The drug molecules have been successfully complexed with HEMA hydrogels to increase their preservation. Structural
characterization was carried out using FTIR to detect the functional groups on the surfaces of drug molecules with different
properties and the HEMA-based hydrogel structure and to determine their complex structures. At the same time, both
pure HEMA structures and interactions between HEMA and drug molecules were shown. Characteristic imine (-N=CH)
stretching vibration of hydrogel and drug molecules was seen at around 1600 cm−1. Broadband around 3300 cm−1 in the
spectra of hydrogel and drug molecules was attributed to the stretching vibration of NH or OH (Figure 2). The observed
peak that is located at 1642 cm-1 is the most significant difference between the loaded hydrogel samples (Figure 2). The peak
at 1642 cm-1 occurred from the conjugated C = O bond. Due to C-O stretching, the peaks at 1070 cm–1 also confirmed the
existence of the ester group of HEMA. The peak observed at 1154 cm–1 can be explained by the C-N stretching vibrations
of the HEMA hydrogel containing the drug molecules of niclosamide and furosemide [37]. There is a significant increase
in band intensities of C = O, C-H, C = C, and C-O stretching vibrations in drug-loaded hydrogel structures compared to
pure drug structures.
The complexation of furosemide, niclosamide, and nifedipine with HEMA hydrogel was visualized with SEM after
FT-IR characterization. The morphological properties of pure hydrogel (Figure 3a) and HEMA hydrogels containing drug
molecules (Figures 3b–3d) were evaluated using SEM. Hydrogels were clearly observed to have porous internal structures
and interconnected pores. The structure of pure hydrogels has been monitored to contain smoother structures compared
to the drug-loaded hydrogels. The morphologies of hydrogels were observed in cell-containing mediums and images were
compared. As drug releases occurred from the drug-loaded hydrogel in the cell environment, crystal structures were
observed on the surface of the hydrogel. Since these crystal-like structures were not observed in the pure hydrogel, these
structures can be considered drug molecules. This image indicated that the hydrogel structure protects and releases the
drug molecules in the presence of cells. As shown in the images, all hydrogel structures clearly displayed the molecules
they contained following the application of the process.

Figure 1. The schematic of the preparation process of HEMA hydrogel and drug-loaded

Figure
1. The schematic of the preparation process of HEMA
HEMA hydrogel, (a) Furosemide, (b) Nifedipine, (c) Niclosamide
hydrogel and drug-loaded HEMA hydrogel, (a) Furosemide, (b)
Nifedipine, (c) Niclosamide.

Figure 2.2.FT-IR
spectra
of pure HEMA
hydrogels
and drug
loaded hydrogels,
the range
Figure
FT-IR
spectra
of pure
HEMA
hydrogels
and in
drug4000–400
cm-1
loaded
hydrogels
in the range 4000–400 cm–1.
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Figure 3. SEM images in cell presence of pure hydrogels and hydrogels

Figure 3. SEM images in cell presence of pure hydrogels and hydrogels containing drug
containing
drug
molecule,
(a) pure
(b)niclosamide
nifedipine
loaded
molecule,
(a) pure
HEMA,
(b) nifedipine
loadedHEMA,
HEMA, (c)
loaded
HEMA, (d)
HEMA, loaded
(c) niclosamide
loaded HEMA, (d) furosemide loaded HEMA.
furosemide
HEMA.

The equilibrium swelling behaviors of the HEMA hydrogels in different buffer solutions (pH 2, pH 4, pH 7, and pH 9)
and water are shown in Figure 4. According to the swelling of HEMA, buffer solution was absorbed more than water. As
the pH was increased, the swelling ability of the hydrogel increased. When the pH exceeds 7, the swelling of the HEMA
structure was influenced negatively. The rising pH of solutions showed that the enlarging of hydrogel speed and size also
increased. The increasing pH causes ionization of the carboxyl groups of MBA. Moreover, this causes the separation
of hydrogen bonds between the carboxylic acid groups of the MBA and the oxygens of the ether groups of the HEMA.
Combined with the electrostatic repulsion force, the dissociation of hydrogen bonds makes the hydrogel network swell
rapidly [38-39]. The fewer hydrogen ions in the body, the better our overall health. The pH of our blood is in the range
of 7.35–7.45 [40]. According to these values, we can say that the pH of our blood is alkaline. In healthy individuals,
intragastric pH ranges from 1.3 to 2.5 in case of hunger, while during eating, pH can reach 7.5. An increase in the pH of
the stomach with the introduction of food into the stomach triggers the secretion of gastric fluid [39-40]. Drug molecules
or active substances are usually taken into the body in satiety. In the case of satiety, the body pH is usually around 7–7.5.
Since the optimal working pH of HEMA hydrogel is around 7, its biological properties do not have any problems.
The rapid drug release from the hydrogel structure was observed in the first hours (Figure 5). Thereafter, a gradually
decreasing rate of release was observed up to 20 h after which the release remained relatively constant. The drugs were not
completely released within 48 h. The percentage of loaded drug amounts released in 48 hours was 68.9 ± 4.7%, 65.2 ± 2.3%,
and 71.3 ± 5.1% for niclosamide, nifedipine, and furosemide, respectively.
Structural features and monomer types of hydrogels are very significant to decide the application field. For instance,
evaluation of the structural properties of hydrogel structures is very important in various biological fields such as drug
delivery, biomedical applications, and tissue engineering. As seen in Table 1, hydrogel structures were used in many areas,
especially drug release. In addition, drug release, solubility, and vasoactivity studies were carried out from some hydrogel
structures of nifedipine, niclosamide, and furosemide drug molecules. In this study, HEMA-based hydrogel structures
containing drug molecules have been designed for cancer therapy. It has been observed that this hydrogel structure swells
when contacted with an aqueous solution and/or pH solution. At the same time, this hydrogel structure releases the drug
molecules it contains by providing the ability to swell in an aqueous environment. In this section, we shall discuss the
swelling of hydrogels for cancer treatment and the release of each drug in the HEMA hydrogel.
The effects of these released drug molecules and hydrogel structure on healthy and cancer cell lines were investigated.
Drug concentrations and cell viability measurements were made over time to evaluate the drug release system of the
drug-containing hydrogels against HEK-293 (Figure 6a), MCF-7 (Figure 6b), and MIA PaCa-2 (Figure 6c) cells. After
reattachment, media of the cells were discarded, and fresh media containing different concentrations of test compounds
(0, 5, 10, 20, 40, 60, 80,100, 120, 140, 160, and 200 µg/mL) were added to each well (Figure 6). Samples were prepared as
triplicates. Only cell-, only media-containing test compounds for each concentration were used as negative control wells.
The drug concentration was determined as 80 µg/mL with the Alamar blue test.
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Figure 4. Equilibrium swelling behavior of hydrogels.

Figure 4. Equilibrium swelling behavior of hydrogels.

Figure
5. 5.Cumulative
in hours.
HEMA hydrogel as a
Figure
Cumulative drug
releaserelease
(%) in 72
function of time. The results are expressed as a mean ± standard
deviation (n = 3).

Figure 6. Viability of (a) HEK 293, (b) MCF-7, and (c) MIA PaCa-2 cells exposed to 0-200 μg/mL

drugs nifedipine,
niclosamide,
and293,
furosemide.
Figure
6. Viability
of (a) HEK
(b) MCF-7 and (c) MIA PaCa-2 cells exposed to 0-200

μg/mL drugs nifedipine, niclosamide and furosemide.

In vitro, drug-release studies were tested with drug-loaded hydrogels to obtain results consistent with cumulative
release results. In vitro release studies were done on HEK 293, MCF-7, and MIA PaCa-2 cell lines (Figures 7a–7c). The
drugs niclosamide, nifedipine, and furosemide caused 62%, 32%, and 42% deaths in MCF-7 cells, respectively. Moreover,
niclosamide, nifedipine, and furosemide caused 64%, 33%, and 50% of deaths in MIA PaCa-2, respectively. However, the
death rate (around 20%) was less observed in the HEK 293 healthy cell line. Niclosamide has been shown to have more
cytotoxic effects on cancer cells than those of furosemide and nifedipine showed.
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Table 1. The hydrogel structure can be studied on different applications as detailed below.
Hydrogel

Drug

Applications

Reference

N‐succinyl chitosan/alginate
hydrogel

Nifedipine

Controlled delivery

[44]

Pectin-co-poly acrylic acid
(Pec-co-poly (AA))

Nifedipine

Controlled delivery

[45]

Hemicellulose-based
hydrogels

BSA

Magnetically stimulated
release

[46]

Alginate bead

Chlorpheniramine

Drug release

[47]

Chitosan hydrogel

Chlorhexidine

Oral, transdermal, nasal,
rectal and ocular drug
delivery

[48]

PMAN

Niclosamide

Solubility and vasoactivity

[49]

HPMC

Furosemide

Forming drug solubilizing
micelles

[50]

HEMA hydrogel

Nifedipine
Niclosamide
Furosemide

Drug release

This work
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The resulting cytotoxicity test bar chart was shown in Figure 8. Using the results of this cytotoxicity test, IC50 values
(semimaximum inhibitory concentrations) were calculated with SigmaPlot 11.0 and are summarized in Table 2.
The Alamar blue experiment was performed using equivalent doses of hydrogels containing the drug molecules.
According to in vitro drug release research, the drug release occurred within the first 72 h. The death of MCF-7, MIA
PaCa-2, and HEK 293 cells was at the maximum after 40–44 h (Figure 8). However, the lethal effects of drug molecules
loaded with hydrogels on HEK-293 were much lower than on MCF-7 and MIA PaCa-2. Application of hydrogel structures
containing the niclosamide to cells for 40 h showed inhibition rates of 62% at the MCF-7, 64% at the MIA PaCa-2, and 18%
at the HEK-293 cell line. As a result of the release of the furosemide from hydrogel to cells, 42%, 50%, and 20% deaths were
observed in MCF-7, MIA PaCa-2, and HEK 293 cell lines, respectively. Hydrogel structures containing nifedipine also
showed inhibition rates of 36% in MCF-7, 45% in MIA PaCa-2, and 17% in the HEK-293 cell line. These results showed
similarity with the results from the 72-h inhibition test. The results of the release and incubation of niclosamide showed
that it has a higher cell death effect than other drug molecules.
HEMA-based hydrogels were demonstrated to be biocompatible with cells, showing good pharmacological potential.
Experiments were conducted on artificial blood samples to support this condition. A safe and effective blood substitute
commonly referred to as “artificial blood” but more scientifically referred to as “oxygen therapeutic agent”, has recently
given quite a boost to in vivo studies. Many trials are conducted on artificial blood to support in vivo studies and successful
results are obtained. In order to support our research, the effects of HEMA hydrogel and drug molecules on artificial
blood were investigated. The results obtained were supported by in vitro studies and the results in vivo are summarized
in Figure 9. As a result of the release of the niclosamide from hydrogel to artificial blood, 46%, 50%, and 22% deaths were
observed in artificial blood containing MCF-7, MIA PaCa-2, and HEK 293 cell lines respectively. Hydrogel structures
containing nifedipine also showed inhibition rates of 33% in MCF-7, 36% in MIA PaCa-2, and 16% in the HEK-293 cell
line. Furosemide drug demonstrated a death rate of 32% in MCF-7, 34% in MIA PaCa-2, 18% in HEK-293 cell line.

Figure 7.
7. Drug
cell
viability
by using
the Alamar
blue assay
(a) HEK
(b) MCF-7
Figure
Drugrelease-induced
release-induced
cell
viability
by using
the Alamar
blueinassay
in; 293,
(a) HEK
293,
cells, and (c) MIA PaCa-2.

(b) MCF-7 cells and (c) MIA PaCa-2.
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Table 2. The IC50 of tested drug molecules in different cell lines (MCF-7, MIA PaCa-2, and HEK 293) after 72-h
incubation.

Compound

Cytotoxicity (IC50, μM)
MCF-7

MIA PaCa-2

HEK 293

Furosemide

95.2 ± 4.7

81.5 ± 5.4

N.D.

Nifedipine

122.3 ± 9.2

118.8 ± 10.6

N.D.

Niclosamide

63.8 ±8.3

66.6 ± 3.9

N.D.

HEMA

N.D.

N.D.

N.D.

Furosemide + HEMA

107.5 ± 7.6

99.1 ± 6.3

N.D.

Nifedipine + HEMA

133.7 ± 9.7

128.5 ± 11.4

N.D.

Niclosamide + HEMA

86.2 ± 10.3

77.3 ± 4.4

N.D.

The data is described as a mean ± SD of three free experimental definitions applied in triplicate
N.D. not detected

Figure 8. Viability of MCF-7, MIA PaCa-2, and HEK 293 cells exposed to pure HEMA and
Figure
8. Viability of MCF-7, MIA PaCa-2, and HEK 293 cells
drug molecules
loadedHEMA
HEMA for
40 h.
exposed
to pure
and
drug molecule-loaded HEMA for 40 h.

Figure 9. Viability of artificial blood containing cancer cells
MCF-7, MIA PaCa-2, and HEK 293 cells exposed to pure HEMA
293
cells exposed
pure HEMA
(control) and drug
molecules
(control)
andtodrug
molecule-loaded
HEMA
forloaded
40 h.HEMA for 40 h.

Figure 9. Viability of artificial blood containing cancer cells MCF-7, MIA PaCa-2, and HEK

The cytotoxicity tests indicated that all drug molecules had moderately and good cytotoxic activity on the cancer cell
lines [51]. The hydrogels containing drug molecules were found to cause more death in cell lines than control and pure
hydrogels. Figure 10 showed that the death rate of cancer cells was higher than healthy cells. As a result, niclosamide is
the most cytotoxic drug, and furosemide also has moderate cytotoxicity. Furthermore, this study suggests that HEMA
hydrogels can be used to preserve drugs and developed as support materials for drug release.
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Figure
10. Growth
effects drug
of different
drug
molecules
(80
µg/mL)
Figure
10. Growth
effects of different
molecules (80
µg/mL)
on MCF-7,
MIA
PaCa-2
on MCF-7,
MIA
PaCa-2,
and HEK 293 cells after 72-h incubation.
and HEK
293 cells after
72-hour
incubation.

Results of cytotoxicity studies and calculated IC50 values were compared. It was observed that the cytotoxicity test
results and the calculated IC50 values were compatible. From the cytotoxicity tests on cancer cells, it was determined that
80–100 μg/mL drug concentration caused the most death. With this concentration, the maximum cell death was found
to be 60%–65% in the presence of a niclosamide drug molecule. With these cytotoxicity test results, the IC50 value was
calculated as 77–86 μg/mL. When the results are evaluated, the results of the cytotoxicity test and the IC50 values (the half
maximal inhibitory concentration) agree with each other. The same cytotoxicity tests and IC50 values were performed and
calculated in HEK 293 healthy cell lines. In HEK 293 cell lines, the maximum mortality rate was observed around 20%
by cytotoxicity test. Since the cytotoxicity test result was around 20%, the IC50 value could not be defined. These results
showed that the cytotoxicity test results and IC50 values gave consistent results.
4. Discussion
This study has focused on improving continuous release systems of nifedipine, furosemide, and niclosamide to improve the
effectiveness of the drug, which exhibits poor water solubility and poor permeability. The poor solubility of the drug limits
its bioavailability and thus greatly reduces its therapeutic efficacy. Hydrogels have been described to improve bioavailability
and protection. The cytotoxic effects of drug molecules have been studied in very few studies. However, the controlled
release of these drug molecules into cancer cells has been studied for the first time. Compared with other studies, it was
determined that the cytotoxic effects of the drug molecules loaded on the HEMA hydrogel were more effective than the
pure drug molecules. These anticancer drugs were observed to be effectuated to a large extent by the circulatory system
in a published article [9]. In addition to reducing the side effects of drug molecules, their protection with hydrogels has
enabled the use of drugs in a healthier way. In many studies, the niclosamide drug molecule has been defined as a more
effective anticancer agent than other drug molecules because it has been proven that the drug niclosamide affects more
cellular mechanisms than other drug molecules. Niclosamide inhibits Wnt/β-catenin, the mammalian target of rapamycin
complex 1, signal transducer and activator of transcription 3 (STAT3), Notch signaling pathways, and nuclear factor-κB,
and targets mitochondria in cancer cells to induce cell cycle arrest, growth inhibition, and apoptosis [27]. A number
of studies have demonstrated the anticancer activities of niclosamide in vitro and in vivo models. As a result, it can be
suggested that HEMA hydrogels prepared within the scope of this study can be drug supplements that can be used in the
release studies of nifedipine, furosemide, niclosamide, and similar drug molecules.
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